In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, highlights a presentation on macular telangiectasia type 2.

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discusses 3-year data from the GALE study on geographic atrophy treatment with pegcetacoplan.

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, highlights a debate on the use of complement inhibitors in geographic atrophy.

In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, highlights data presented at Retina Subspecialty Day.

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

An oral 11‐beta hydroxylase inhibitor administered during the evening reduced systolic and diastolic blood pressure for ...

Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...

Numerous barriers prevent individuals with cancer who are incarcerated from getting equitable care, including care ...

Since 2013, the Mohs micrographic surgery workforce has become dominated by fellowship-trained Mohs surgeons; however, a few ...

The FDA approved pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph in combination with enfortumab vedotin-ejfv ...

Pregnant individuals with rheumatic diseases who were exposed to disease-modifying antirheumatic drugs did not experience ...

Sexual and reproductive health care has long been vulnerable to myths, misinformation and disinformation. The increasing ...